Year in Review: Bay Area fed its drug habit with FDA approvals

No blockbusters, but the Bay Area's drug-development engine continued to produce a wide range of therapeutics in 2021. From a drug-implant developed by Genentech Inc. of South San Francisco for people with the eye disease wet age-related macular degeneration to San Mateo-based Myovant Sciences Ltd.'s treatment for women with heavy menstrual bleeding due to severe uterine fibroids, biotech and traditional drug deve lopers continued a long streak of Food and Drug Administration approvals. This slideshow…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news